The largest database of trusted experimental protocols

Fitc anti human cd80 antibody

Manufactured by BioLegend
Sourced in United States

The FITC anti-human CD80 antibody is a reagent used for the identification and quantification of CD80-positive cells in flow cytometry applications. CD80, also known as B7-1, is a costimulatory molecule expressed on the surface of antigen-presenting cells and plays a crucial role in T cell activation.

Automatically generated - may contain errors

2 protocols using fitc anti human cd80 antibody

1

Isolation and Differentiation of Human Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh PBMCs from two healthy donors were separated from whole blood samples using Ficoll-PaqueTM. CD14+ monocytes were selected using MACS human CD14 MicroBeads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany), pre-separation filters (Miltenyi), and LS columns (Miltenyi) following the manufacturer’s recommendations. To induce M0 macrophages, isolated CD14+ monocytes were seeded onto FBS-coated 24-well plates at a density of 1 × 105 cells/cm2. Seeded cells were cultured for 7 days in RPMI 1640 media supplemented with 20% FBS and 100 ng/ml M-CSF (BioLegend, San Diego, CA, USA). On day 7, M-CSF-containing medium was removed, and appropriate stimulating media containing 100 ng/ml LPS (Sigma-Aldrich, St. Louis, MO, USA) and 20 ng/ml IFN-γ (BioLegend) for M1 induction or 20 ng/ml IL-4 (BioLegend) and 20 ng/ml IL-10 (BioLegend) for M2 induction were supplied. After an additional 48 h of culture, cells were collected by gentle scraping and then taken for fluorescence-activated cell sorting (FACS) analysis or scRNA-seq. The morphological changes that occurred during differentiation were observed every 2 days under a microscope. A fraction of the cells was triple-stained with PE/Cy7 anti-human CD14 antibody (BioLegend), FITC anti-human CD80 antibody (BioLegend), and PE anti-human CD163 antibody (BioLegend) and analyzed by FACSVerse and FACSuite v1.2 (BD Biosciences).
+ Open protocol
+ Expand
2

Quantifying CD80 Expression in LPS-treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We harvested the cells 24 hours after LPS administration. The cells were stained with an FITC-anti-human CD80 antibody (BioLegend, San Diego, California, USA) or FITC mouse IgG1, k isotype (Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA) for 30 minutes at 4°C after blocking the nonspecific Fc receptor using FC blocking reagent human (Miltenyi Biotec) for 10 minutes. After staining, the cells were washed immediately and resuspended in AutoMACS Runnig Buffer. Fluorescence data were collected using an Attune NxT Flow Cytometer, and the FITC-positive cell population was evaluated using an excitation wavelength of 488 nm. The flow cytometry files were analyzed using FlowJo software (Becton, Dickinson and Company).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!